PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1252667
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1252667
Custom Antibody Market size was valued at USD 590.1 Million in 2022, expanding at a CAGR of 10.8% from 2023 to 2030.
90% purified antigen is used by the supplier to create or develop a custom antibody for a particular antigen. Custom antibody manufacturing is used to create both polyclonal and monoclonal antibodies. Peptide design, peptide design, animal immunization, serum collection, titer analysis, and antibody purification are the stages in the production of custom polyclonal antibodies. Preparation of the antigen, hybridoma development immunizations, hybridoma development fusions, monoclonal production, and purification are the stages in the production of a custom monoclonal antibody. Comparatively speaking to the typically cultured antibodies, the custom antibody has greater selectivity.
Due to lengthy development times and approval cycles, the R&D industry has historically required a lot of capital. R&D investments make up a sizeable portion of worldwide spending. Governments understand that investing in R&D is essential for a country's development, global competitiveness, and general good. As a result, financing and spending for R&D have been rising steadily over time. In 2021, more than 116 countries will spend a total of USD 2.7 trillion on R&D businesses, government laboratories, and academic research facilities. The sudden COVID-19 outbreak caused a significant shift in R&D expenditure all over the world. While China saw a historic investment of 12.0% of its annual growth in 2020, other nations saw a significant drop in their R&D spending. R&D spending in the top 10 nations came to a sum of 79.4% in 2020, and it is anticipated that this percentage will not change in 2021. Currently, there is a greater emphasis on biopharmaceutical R&D due to the growing demand for effective therapeutic medicines with fewer side effects. Pharmaceutical research and development accounts for about 80% of all R&D spending in the life sciences sector. Large pharmaceutical firms like Pfizer, Merck, and Switzerland's F. Hoffmann-La Roche Ltd (US). The biopharmaceutical industry, which invests nearly USD 50 billion in R&D yearly, is largely responsible for the industry's R&D expenditures. Similar to how funding from organizations for different genomic projects is advancing this field's research. The general purchase and consumption of antibodies are anticipated to be driven by a rise in research activity and the availability of funding. This will accelerate the market for customized antibodies.
The Global Custom Antibody Market is segmented into Product, Source, Application, End-user and Region.
Based on the product, the monoclonal segment is expected to dominate the market during the forecast period. High R&D expenditures by significant market participants are responsible for this dominating market dominance. Additionally, it is anticipated that the clinical urgency to integrate these systems will be driven by the rising risk of chronic diseases associated with lifestyle choices, fueling demand for custom antibodies over the forecast period. However, since custom monoclonal antibodies are generally more costly, end users must pay a higher production cost. Therefore, the high expense of production is expected to slow segment growth over time.
Based on the source, the rabbit segment is expected to grow at the highest CAGR over the forecast period. The rabbit is an excellent choice for study on protein and peptide antigens because it is a frequent host in the production of antibodies. Technology is being developed by businesses to facilitate the expansion of antibodies based on rabbits. For instance, one of the technologies on the market for creating custom monoclonal antibodies and capable of producing them in large numbers is GenScript's MonoRab. Thus, driving segmental growth.
North America accounted for the largest market share in 2022 due to the presence of significant businesses, significant government investment, and an increase in research efforts in the region. Universities in the U.S. and Canada also run extensive programs for cancer and genomics study. These have accelerated the biotechnology industry's development, which has raised the demand for high-throughput technology options in lab workflows. North America's market dominance is anticipated to remain unchallenged during the forecast period as a result of the region's rapid adoption of cutting-edge technological solutions, significant expenditures in R&D, and increasing wages for highly qualified workers.
This proposed research study on the Custom Antibody market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Custom Antibody market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Custom Antibody market
The impact of COVID-19 on the Custom Antibody market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Custom Antibody market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Custom Antibody market, we have also included a competitive landscape and key innovator analysis for the Custom Antibody market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Custom Antibody market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Custom Antibody market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
The scope of this report covers the market by its major segments, which include as follows:
Thermo Fisher Scientific Inc.
Merck KGaA
Cell Signaling Technology Inc.
Rockland Immunochemicals
BioLegend
GenScript
Bio-Rad Laboratories Inc.
Abcam PLC
Agilent Technologies
Innovagen Ab
ProMab Biotechnologies
Proteogenix
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
GLOBAL CUSTOM ANTIBODY MARKET, BY SOURCE
Rabbit
Chicken
Guinea pig
Goat
Mouse
Others (Rat and Others)
Oncology
Infectious diseases
Immunology
Neurobiology
Stem cells
Other (Cardiovascular Disease and Others)
Pharmaceutical & biotechnology companies
Academic & research institutes
Contract research organizations
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA